Institutional investors hold a majority ownership of ILMN through the 96.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $1.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 1.1 Million shares of Illumina Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 532.7 Thousand shares of Illumina Inc
COLUMBIA MANAGEMENT INVESTMENT A... Bought 519.2 Thousand shares of Illumina Inc